The Human Variable 

Climate change is accelerating fungal evolution at the same moment millions of Americans are living with post-COVID immune instability. This white paper introduces CYNAERA’s national fungal-intelligence architecture, integrating climate analytics, immune-terrain modeling, wastewater genomics, micro-clinic stabilization, and antifungal combination logic. It explains why fungal threats are rising, how existing federal infrastructure can be repurposed immediately and what the Un

The Physics of Survival reframes human stability as the core infrastructure of civilization. This white paper introduces Terrain Intelligence—a unifying systems framework that links space medicine, chronic illness, and climate resilience under one predictive model. Drawing on NASA Human Research Program findings and longitudinal public-health data, Cynthia Adinig demonstrates that physiological collapse in microgravity mirrors the same autonomic and immune failure seen in Lon

FEMA’s flood plans overlook infection-associated chronic conditions now affecting one-quarter of U.S. adults. This CYNAERA white paper introduces biologic disaster modeling using US-CCUC™, ESA™, VitalGuard™, and MoldX™ to forecast medical surges from mold, heat, and power loss. Applying these systems could prevent 70 percent of non-trauma ER visits and save $7.4 billion annually in federal costs.

Traditional medicine isolates diagnoses by organ or specialty. CYNAERA’s terrain logic views the body as an interdependent system where immune, endocrine, and autonomic signals co-determine stability. The Playbook applies three key insights from the Primary Chronic Trigger (PCT) Blueprint. Chronic illness begins with temporal ignition, an event that tips an unstable terrain. Chronicity persists when recovery conditions (RC) remain incomplete.

The CYNAERA Primary Chronic Trigger (PCT) framework embeds PEM as a probability-weighted conversion event inside a prevalence model that accounts for viral exposure, environmental load, climate volatility, and recovery suppression. Modeled remission rises from historical 12–18 percent toward 35–50 percent under PEM-aware, terrain-timed designs, with early-intervention subsets reaching 42–60 percent in best-case conditions.

This future ready framework was built from real world data, patient-led insights and cutting-edge biomarker science. 35–50 million Americans. 25–30% global prevalence. $1 trillion annual impact. The world can’t afford diagnostics that guess, it needs diagnostics that know. Read the groundbreaking Composite Diagnostic Fingerprint for Long COVID, authored by patient-turned-subject matter expert Cynthia Adinig. Nobel Prize worthy thinking. Welcome to CYNAERA. Where technology m